Skip to main content
. 2023 Sep 18;30(9):8563–8574. doi: 10.3390/curroncol30090621

Figure 3.

Figure 3

Kaplan–Meier curves of overall survival for 5-FU-treated patients (group 1) versus capecitabine-treated (group 2) patients.